Jiangsu Hengrui Medicine Co., Ltd. revenue reports
Jiangsu Hengrui Medicine Co., Ltd. financial reports, Jiangsu Hengrui Medicine Co., Ltd. annual revenue in 2024. When does Jiangsu Hengrui Medicine Co., Ltd. report revenue?
Jiangsu Hengrui Medicine Co., Ltd. total revenue, net income and dynamics of changes in yuan today
The dynamics of Jiangsu Hengrui Medicine Co., Ltd. net revenue decreased by -1 392 418 787 ¥ from the last reporting period. Jiangsu Hengrui Medicine Co., Ltd. net income is now 1 496 547 609 ¥. The dynamics of net income of Jiangsu Hengrui Medicine Co., Ltd. has changed by -573 243 482 ¥ in recent years. Jiangsu Hengrui Medicine Co., Ltd. financial report on the graph shows the dynamics of assets. Information on Jiangsu Hengrui Medicine Co., Ltd. net income on the chart on this page is drawn in blue bars. A graph of the value of all Jiangsu Hengrui Medicine Co., Ltd. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
6 929 054 893 ¥
+39.51 % ↑
1 496 547 609 ¥
+25.49 % ↑
31/12/2020
8 321 473 680 ¥
+67.8 % ↑
2 069 791 091 ¥
+79.41 % ↑
30/09/2020
8 104 243 144 ¥
+17.13 % ↑
1 596 674 940 ¥
+20.74 % ↑
30/06/2020
5 781 866 606 ¥
+14.28 % ↑
1 346 491 269 ¥
+10.38 % ↑
30/09/2019
6 918 746 432 ¥
-
1 322 431 598 ¥
-
30/06/2019
5 059 445 975 ¥
-
1 219 857 587 ¥
-
31/03/2019
4 966 854 058 ¥
-
1 192 604 214 ¥
-
31/12/2018
4 959 132 703 ¥
-
1 153 688 791 ¥
-
Show:
to
Jiangsu Hengrui Medicine Co., Ltd. financial report charts
Dates of Jiangsu Hengrui Medicine Co., Ltd. finance reports: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Jiangsu Hengrui Medicine Co., Ltd. is 31/03/2021. Gross profit Jiangsu Hengrui Medicine Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Jiangsu Hengrui Medicine Co., Ltd. is 6 018 656 444 ¥
Jiangsu Hengrui Medicine Co., Ltd. quarterly report dates
Cost of revenue Jiangsu Hengrui Medicine Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Jiangsu Hengrui Medicine Co., Ltd. is 910 398 449 ¥ Total revenue Jiangsu Hengrui Medicine Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Jiangsu Hengrui Medicine Co., Ltd. is 6 929 054 893 ¥ Operating income Jiangsu Hengrui Medicine Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Jiangsu Hengrui Medicine Co., Ltd. is 1 659 648 279 ¥
Net income Jiangsu Hengrui Medicine Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Jiangsu Hengrui Medicine Co., Ltd. is 1 496 547 609 ¥ Current assets Jiangsu Hengrui Medicine Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Jiangsu Hengrui Medicine Co., Ltd. is 29 240 657 590 ¥ Total assets Jiangsu Hengrui Medicine Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Jiangsu Hengrui Medicine Co., Ltd. is 36 157 171 056 ¥
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 018 656 444 ¥
7 350 055 475 ¥
7 083 443 562 ¥
5 159 015 403 ¥
6 080 824 469 ¥
4 401 220 460 ¥
4 290 518 829 ¥
4 298 864 258 ¥
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
910 398 449 ¥
971 418 205 ¥
1 020 799 582 ¥
622 851 203 ¥
837 921 963 ¥
658 225 515 ¥
676 335 229 ¥
660 268 445 ¥
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 929 054 893 ¥
8 321 473 680 ¥
8 104 243 144 ¥
5 781 866 606 ¥
6 918 746 432 ¥
5 059 445 975 ¥
4 966 854 058 ¥
4 959 132 703 ¥
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
6 918 746 432 ¥
5 059 445 975 ¥
4 966 854 058 ¥
4 959 132 703 ¥
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 659 648 279 ¥
1 514 060 209 ¥
1 823 003 262 ¥
1 421 981 334 ¥
1 469 637 265 ¥
1 281 724 692 ¥
1 352 183 996 ¥
845 011 123 ¥
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 496 547 609 ¥
2 069 791 091 ¥
1 596 674 940 ¥
1 346 491 269 ¥
1 322 431 598 ¥
1 219 857 587 ¥
1 192 604 214 ¥
1 153 688 791 ¥
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 316 228 078 ¥
1 644 840 156 ¥
1 480 703 846 ¥
1 052 209 235 ¥
1 415 363 102 ¥
822 494 833 ¥
661 620 319 ¥
933 976 313 ¥
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 269 406 614 ¥
6 807 413 471 ¥
6 281 239 882 ¥
4 359 885 272 ¥
5 449 109 167 ¥
3 777 721 283 ¥
3 614 670 062 ¥
4 114 121 580 ¥
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
29 240 657 590 ¥
28 050 035 998 ¥
25 569 303 207 ¥
23 777 925 758 ¥
21 512 152 951 ¥
20 038 014 121 ¥
18 959 391 591 ¥
18 069 392 095 ¥
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
36 157 171 056 ¥
34 729 589 910 ¥
32 535 474 246 ¥
29 677 472 561 ¥
25 952 860 474 ¥
24 411 927 038 ¥
23 181 490 112 ¥
22 361 229 601 ¥
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
12 571 194 483 ¥
10 804 668 034 ¥
11 050 932 380 ¥
9 562 883 398 ¥
3 956 571 130 ¥
4 348 444 809 ¥
4 266 504 785 ¥
3 889 711 308 ¥
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
2 562 723 549 ¥
2 456 189 221 ¥
2 610 905 640 ¥
2 493 634 128 ¥
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
2 697 702 936 ¥
2 573 046 321 ¥
2 685 714 820 ¥
2 563 491 128 ¥
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
10.39 %
10.54 %
11.59 %
11.46 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
32 189 397 619 ¥
30 504 303 351 ¥
28 246 290 821 ¥
26 546 909 505 ¥
23 153 223 795 ¥
21 768 521 996 ¥
20 425 193 388 ¥
19 728 178 443 ¥
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
1 155 609 167 ¥
1 025 251 356 ¥
427 238 760 ¥
723 604 956 ¥
Last revenue report of Jiangsu Hengrui Medicine Co., Ltd. was 31/03/2021. According to last financial report total revenue in Jiangsu Hengrui Medicine Co., Ltd. was 6 929 054 893 yuan and changed by +39.51% since last year. Net income in Jiangsu Hengrui Medicine Co., Ltd. was 1 496 547 609 ¥ in last quartal, net income changes to +25.49%.
Current cash Jiangsu Hengrui Medicine Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Jiangsu Hengrui Medicine Co., Ltd. is 12 571 194 483 ¥
